Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization
- PMID: 29518103
- PMCID: PMC5843221
- DOI: 10.1371/journal.pone.0193643
Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization
Abstract
Monocytes and macrophages constitute the first line of defense of the immune system against external pathogens. Macrophages have a highly plastic phenotype depending on environmental conditions; the extremes of this phenotypic spectrum are a pro-inflammatory defensive role (M1 phenotype) and an anti-inflammatory tissue-repair one (M2 phenotype). The Inhibitor of Apoptosis (IAP) proteins have important roles in the regulation of several cellular processes, including innate and adaptive immunity. In this study we have analyzed the differential expression of the IAPs, NAIP, cIAP1 and cIAP2, during macrophage differentiation and polarization into M1 or M2. In polarized THP-1 cells and primary human macrophages, NAIP is abundantly expressed in M2 macrophages, while cIAP1 and cIAP2 show an inverse pattern of expression in polarized macrophages, with elevated expression levels of cIAP1 in M2 and cIAP2 preferentially expressed in M1. Interestingly, treatment with the IAP antagonist SMC-LCL161, induced the upregulation of NAIP in M2, the downregulation of cIAP1 in M1 and M2 and an induction of cIAP2 in M1 macrophages.
Conflict of interest statement
Figures






Similar articles
-
LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.J Exp Clin Cancer Res. 2016 Sep 30;35(1):158. doi: 10.1186/s13046-016-0435-7. J Exp Clin Cancer Res. 2016. PMID: 27737687 Free PMC article.
-
Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells.Gastroenterology. 2017 Mar;152(4):867-879. doi: 10.1053/j.gastro.2016.11.019. Epub 2016 Nov 24. Gastroenterology. 2017. PMID: 27889570
-
Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.Cell Death Differ. 2011 Aug;18(8):1376-86. doi: 10.1038/cdd.2011.10. Epub 2011 Feb 18. Cell Death Differ. 2011. PMID: 21331077 Free PMC article.
-
Inhibitors of apoptotic proteins: new targets for anticancer therapy.Chem Biol Drug Des. 2013 Sep;82(3):243-51. doi: 10.1111/cbdd.12176. Chem Biol Drug Des. 2013. PMID: 23790005 Review.
-
Small-molecule SMAC mimetics as new cancer therapeutics.Pharmacol Ther. 2014 Oct;144(1):82-95. doi: 10.1016/j.pharmthera.2014.05.007. Epub 2014 May 16. Pharmacol Ther. 2014. PMID: 24841289 Free PMC article. Review.
Cited by
-
Studying Signaling Pathway Activation in TRAIL-Resistant Macrophage-Like Acute Myeloid Leukemia Cells.Acta Naturae. 2024 Jan-Mar;16(1):48-58. doi: 10.32607/actanaturae.27317. Acta Naturae. 2024. PMID: 38698963 Free PMC article.
-
cIAP2-mediated IGF2BP2 ubiquitination and degradation regulate cardiomyocyte apoptosis via stabilizing m6A-modified BAX mRNA in myocardial infarction.Cell Biol Toxicol. 2025 May 30;41(1):92. doi: 10.1007/s10565-025-10045-3. Cell Biol Toxicol. 2025. PMID: 40447880 Free PMC article.
-
Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells.PLoS One. 2023 Jun 8;18(6):e0286783. doi: 10.1371/journal.pone.0286783. eCollection 2023. PLoS One. 2023. PMID: 37289679 Free PMC article.
-
Comprehensive analysis of an endoplasmic reticulum stress-related gene prediction model and immune infiltration in idiopathic pulmonary fibrosis.Front Immunol. 2024 Jan 11;14:1305025. doi: 10.3389/fimmu.2023.1305025. eCollection 2023. Front Immunol. 2024. PMID: 38274787 Free PMC article.
-
Doxycycline and Zinc Loaded Silica-Nanofibrous Polymers as Biomaterials for Bone Regeneration.Polymers (Basel). 2020 May 25;12(5):1201. doi: 10.3390/polym12051201. Polymers (Basel). 2020. PMID: 32466191 Free PMC article.
References
-
- Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nature Reviews Immunology. 2014;14(6):392–404. doi: 10.1038/nri3671 - DOI - PubMed
-
- Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nature Reviews Immunology. 2005;5(12):953–964. doi: 10.1038/nri1733 - DOI - PubMed
-
- Italiani P, Boraschi D. From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation. Frontiers in Immunology. 2014;5(OCT):1–22. doi: 10.3389/fimmu.2014.00514 - DOI - PMC - PubMed
-
- Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology. 2008;8(12):958–969. doi: 10.1038/nri2448 - DOI - PMC - PubMed
-
- Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor B. Proceedings of the National Academy of Sciences. 2009;106(35):14978–14983. doi: 10.1073/pnas.0809784106 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous